Advertisement

Indications in neuroscience and multiple sclerosis : the past; the issues; the future. Andy Smith casts an investors eye at neurological disorders, particularly Alzheimers disease, Guillian-Barre Syndrome and multiple sclerosis. He looks at why investors find this a difficult area to predict clinical success and explores drug discovery process, interferons and new treatments.

A series of expert analysis and commentary on the Life Science sector. Join the discussion; share your views.

You need to upgrade your Flash Player!

This web site makes use of the Macromedia Flash player 8.

VIDEO PLAYER by 3b nexus
Advertisement
Advertisement